Concepedia

UHPLC Method Development for Determining Sitagliptin and Dapagliflozin in Lipid-Based Self-Nanoemulsifying Systems as Combined Dose in Commercial Products and its Application to Pharmacokinetic Study of Dapagliflozin in Rats

Mohsin Kazi, Abdulmohsen Alqahtani, Badr Alsaadi, Musaed Alkholief, Fars K. Alanazi

Pharmaceutical Chemistry Journal · 2019 · 17 citations · 2 references

Concepts

PharmacyPharmacokineticsPharmacologyBioavailabilitySelf-emulsifying Drug Delivery SystemsDissolution Of Lipid-based FormulationsLipid-based Solid Dosage FormsNanoemulsionsPharmacokinetic Study DesignPharmacokinetics Of Lipid EmulsionSelf-nanoemulsifying Drug Delivery SystemsSolid Self-emulsifying Drug Delivery Systems

References

2

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

Julio Rosenstock, Lars Hansen, Pamela Zee et al. · Diabetes Care · 2014 · 287 citations

Medicine, Pharmacology, Pharmacotherapy +17

Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Serge Jabbour, Elise Hardy, Jennifer Sugg et al. · Diabetes Care · 2013 · 286 citations

Pharmacy, Pharmacology, Pharmacotherapy +17